CAS RN: 2174002-16-3
Palbociclib-025
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
97% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20251224
50mg
Out of stock
8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 2174002-16-3
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.1g
≥95%
0
Out of Stock
Shanghai
Inquiry
2174002-16-3 / 4-[6-[(6-acetyl-8-cyclopentyl-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridinyl]piperazine-1-carbaldehyde
Standard CAS: 2174002-16-3
Multi CAS: No
Basic Information
copy
CAS
2174002-16-3 copy
Multi CAS
No copy
Molecular Formula
C25H29N7O3 copy
Molecular Weight
475.500000 copy
Exact Mass
475.233188 copy
SMILES
CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCN(CC4)C=O)C5CCCC5)C(=O)C copy
InChI
InChI=1S/C25H29N7O3/c1-16-20-14-27-25(28-21-8-7-19(13-26-21)31-11-9-30(15-33)10-12-31)29-23(20)32(18-5-3-4-6-18)24(35)22(16)17(2)34/h7-8,13-15,18H,3-6,9-12H2,1-2H3,(H,26,27,28,29) copy
InChIKey
KVICSWHDXLNVAO-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
35 copy
Aromatic heavy atom count
16 copy
Fraction Csp3
0.44 copy
Rotatable bonds
6 copy
H-bond acceptors
9 copy
H-bond donors
1 copy
Molar refractivity
133.41 copy
TPSA
113.32 copy
LogP / Solubility
WLOGP
2.83 copy
MLOGP
2.53 copy
XLogP3
1.8 copy
Consensus LogP
2.39 copy
Log S (ESOL)
-4.52 copy
Class (ESOL)
Slightly soluble copy
Log S (Ali)
-5.51 copy
Class (Ali)
Slightly soluble copy
Log S (SILICOS-IT)
-5.82 copy
Class (SILICOS-IT)
Slightly soluble copy
ADME
GI absorption
High copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
Yes copy
Log Kp (skin permeation)
-3.61 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
3.5 copy